Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · IEX Real-Time Price · USD

3.170

+0.230 (7.82%)

At close: Jul 2, 2024, 4:00 PM

3.090

-0.080 (-2.52%)

After-hours: Jul 2, 2024, 4:24 PM EDT

Tenax Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2000
Selling, General & Admin	5.01	5.68	7.58	5.31	5.08	Upgrade
Research & Development	3.23	5.38	25.15	4.56	3.47	Upgrade
Operating Expenses	8.23	11.05	32.73	9.87	8.56	Upgrade
Operating Income	-8.23	-11.05	-32.73	-9.87	-8.56	Upgrade
Interest Expense / Income	0.02	0	0	0	0	Upgrade
Other Expense / Income	-0.55	-0.01	-0.25	-0.02	-0.16	Upgrade
Pretax Income	-7.71	-11.05	-32.47	-9.85	-8.39	Upgrade
Net Income	-7.71	-11.05	-32.47	-9.85	-8.39	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change	1250.92%	43.00%	98.50%	67.33%	295.91%	Upgrade
EPS (Basic)	-31.04	-600.71	-2524.80	-1520.00	-2160.00	Upgrade
EPS (Diluted)	-31.04	-600.71	-2524.80	-1520.00	-2160.00	Upgrade
Free Cash Flow	-5.9	-11.39	-10.86	-9.28	-7.56	Upgrade
Free Cash Flow Per Share	-23.75	-619.37	-844.54	-1431.84	-1952.34	Upgrade
EBITDA	-7.68	-10.93	-32.36	-9.74	-8.29	Upgrade
Depreciation & Amortization	0.01	0.11	0.11	0.11	0.11	Upgrade
EBIT	-7.69	-11.04	-32.47	-9.85	-8.39	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).